Professor Dilip Nathwani elected BSAC President-Elect
The British Society for Antimicrobial Chemotherapy (BSAC) is delighted to announce the election of Professor Dilip Nathwani as BSAC President-Elect at the BSAC Annual General Meeting on 20 March 2014. Professor Nathwani will serve a one year term of office, before taking up office as President 2015-2018.
A long standing member of BSAC and past Member of Council, Professor Nathwani has worked as a Consultant Physician in Infectious Diseases at Ninewells Hospital, Dundee since 1993, where he also holds the position of Honorary Professor of Infection. He has over 25 years clinical experience, has led a successful governmental funded national stewardship programme in Scotland for the past 6 year and is active internationally, most latterly supporting stewardship in Europe through his Chairmanship of the European Society for Clinical Microbiology and Infectious Disease study group for antibiotic policies [ESGAP].
In speaking of his appointment Professor Nathwani said:
“I am delighted to accept this exciting challenge. It is critical that resistance and infections are seen as a patient safety emergency and that we harness a range on established and novel improvement methods to combat this immense challenge. We owe this to the present and future populations we serve. With the support of colleagues in NHS Tayside, the University of Dundee and BSAC these diverse skills will allow me with colleagues to support the implementation of many evidence based interventions to combat the threat of antimicrobial resistance.”
In turn BSAC Council is delighted to welcome his appointment and looks forward to him taking up post and steering the Society through what is undoubtedly one of the most challenging periods as it supports international moves to combat antimicrobial resistance and regenerate interest in antibacterial drug discovery and development.
Mrs Tracey Guise
Chief Executive Officer
0121 236 1988